-+ 0.00%
-+ 0.00%
-+ 0.00%

Azelis (ENXTBR:AZE) Stock Faces Margin Pressure Despite Steady Earnings

Simply Wall St·07/31/2026 18:17:48
Listen to the news

Azelis Group went into these results with a stock that had quietly climbed about 20% over the past month, yet still trades near €11. Today the chemicals distributor put the focus squarely on profitability. Net income for the first half of 2026 came in at €85.2m on revenue of €2,165.8m. This keeps the spotlight on margins for a business that recently ran a trailing net margin of 2.7%.

For you as an investor, the tension is clear. The share price looks muted against a business that is still producing solid absolute earnings, while a P/E of 24.4x keeps questions about valuation firmly on the table.

Love the steady earnings base at Azelis Group but concerned that a 24.4x P/E leaves you paying up for modest margins? Take a look at our 260 high quality undervalued stocks for stocks that pair earnings power with valuation support.

H1 2026 Earnings Summary

  • Revenue (H1 2026 vs. H1 2025): €2,165.76m vs. €2,158.93m (broadly stable)
  • Net Income (Excl. Extra Items, H1 2026 vs. H1 2025): €85.16m vs. €83.55m (broadly stable)
  • Basic EPS (H1 2026 vs. H1 2025): €0.350 vs. €0.343 (broadly stable)
  • Trailing 12-month Net Profit Margin (Latest vs. Prior Year): 2.7% vs. 4.0% (margin lower year on year)

Prefer clean visuals instead of another wall of earnings tables and margin figures for Azelis Group? See the full financial picture, including how its valuation compares, in an easy dashboard view via our company report for Azelis Group.

ENXTBR:AZE Trailing 12-Month Revenue & Expenses Breakdown as at Jul 2026
ENXTBR:AZE Trailing 12-Month Revenue & Expenses Breakdown as at Jul 2026

Azelis Bull Case Hinges On Quality Of Recovery

Bulls argue Azelis can lean on higher margin Life Sciences, better integration of acquired businesses and richer digital and sustainability services to grow revenue per customer and lift margins. The latest half shows only partial progress. Revenue and net income are broadly stable and basic EPS edges up to €0.350, which supports the idea of a resilient earnings base but not yet a clear margin rebuild, with the trailing net margin at 2.7%.

On the capital allocation side, the AGM approval of a dividend, renewed buyback authority and completion of the LTIP share repurchase programme give concrete evidence of the shareholder friendly stance highlighted in the bullish narrative. Gimv building a stake above 5% adds an aligned long term investor to the register, which fits the thesis that external holders see value in Azelis’ platform even as operational proof points on faster margin recovery are still emerging.

Compare Azelis Group’s internal story of resilient earnings, capital returns and a new long term holder with how institutional analysts are framing the risk reward. See the consensus price target analysis for Azelis Group to check where the street has its targets and how that compares with the current €11.31 share price.

Azelis Bears Still Waiting For Clear Stress Signals

The core worry around Azelis Group is that uneven end markets, heavier working capital and rising costs eventually crack margins and cash generation. This half does not fully back that up, but it does not really ease it either. Revenue and net income are broadly stable, yet the trailing net margin at 2.7% versus 4.0% a year earlier shows the margin pressure the bearish narrative flags is already visible and not yet repaired.

Concerns about leverage, liquidity and M&A integration remain largely untested by fresh disclosure in these numbers. There is no clear evidence of working capital relief or stronger free cash flow. UBS trading around the 3% line looks more like short term positioning than a vote on balance sheet strength or weakness. The main miss is on margin recovery milestones. The print keeps bears’ caution alive rather than clearly disproving it.

After a year of margin compression and concern about debt, it is worth asking whether these are isolated issues or signs of deeper fragility. Review the full risk analysis for Azelis Group which shows 2 important warning signs

Stay Ahead With Azelis Group And Beyond

If the mix of steady earnings and margin questions at Azelis Group has your attention, register for free with Simply Wall St and add it to a Watchlist so you can track its share price against fair value and watch for an entry point that fits your plan. Once you own shares, use the Portfolio Command Center to cut through market noise and focus on clear, data driven updates that matter for your holdings. For a longer term view, tap into crowd insights through the Community and see how other investors are thinking about the same signals. By spotting potential catalysts and risks early, you can make decisions with more confidence and stay a step ahead of the market.

Seeking Alternatives Beyond Azelis Group?

Fresh stock ideas can move from quiet potential to full breakout before most investors notice. Use these curated lists while they are under the radar for now and get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.